News - Strides Arcolab, Generics

Filter

Current filters:

Strides ArcolabGenerics

Popular Filters

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Mylan stumbles in $1.6 billion bid to take over injectables specialist Agila Specialties in India

09-07-2013

US generics and specialty drugs company Mylan (NYSE: MYL) faces a setback in its plan to acquire Indian…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesStrides Arcolab

Pfenex and Agila Biotech set up JV to develop biosimilars

16-04-2013

US biotech firm Pfenex Inc. and Agila Biotech, a subsidiary of Indian drugmaker Strides Arcolab (BO:…

Agila BiotechBayerBetaferonBetaseronBiotechnologyGenericsGlobalNeurologicalPfenexProductionResearchStrides Arcolab

GlobalData views potential of Pfizer's rumored acquisition of Strides' Agila unit

20-01-2013

As drug makers continue to jostle for market share and deal with declining revenues from their off-patent…

Agila SpecialitesGenericsMergers & AcquisitionsPfizerPharmaceuticalStrides Arcolab

Eli Lilly in deal with Strides Arcolab for cancer drugs in emerging markets

06-12-2012

US pharma major Eli Lilly (NYSE: LLY) and Indian drugmaker Strides Arcolab (BO: 532531) have entered…

Asia-PacificEli LillyGenericsLicensingMarkets & MarketingStrides Arcolab

News briefs: Drug majors eyeing Strides Arcolab unit; Astellas invests in oncology facility

20-08-2012

Leading drug multinationals, including global behemoth Pfizer (NYSE: PFE) and Swiss major Novartis (NOVN:…

Agila SpecialitesAstellas PharmaGenericsHospiraMergers & AcquisitionsNovartisPfizerPharmaceuticalProductionStrides Arcolab

Strides Arcolab unit enters Canada's injectable generics market via JV

16-07-2012

Agila Specialties Pharma Canada, which is part of the injectable drug division of Indian generic drugmaker…

Agila SpecialitesAgila-JampGenericsJamp PharmaMarkets & MarketingMergers & AcquisitionsNorth AmericaStrides Arcolab

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

Strides Arcolab gets two more cancer generics approved in USA

27-11-2011

Onco Therapies, a wholly owned subsidiary of Indian generics drugmakers Strides Arcolab (BO: 532531),…

CarboplatinGenericsMarkets & MarketingNorth AmericaOnco TherapiesOncologyOxaliplatin InjectionPfizerRegulationStrides Arcolab

Back to top